Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory

Affiliations

• ¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ² Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ³ Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁵ Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁶ Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, USA.
• ⁷ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁸ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁹ School of Biomedical Informatics, The University of Texas Health Science Center at Houston, TX, USA.
• ¹⁰ Division of General Internal Medicine, Medical School, The University of Texas Health Science Center at Houston, TX, USA.
• ¹¹ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ¹² Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.